Open Access Repository

Renal pharmacists' perceptions and current practices of assessing medication adherence in dialysis patients

Ghimire, S ORCID: 0000-0002-2538-9433, Banks, C, Jose, MD ORCID: 0000-0002-9589-0071, Castelino, RL and Zaidi, STR ORCID: 0000-0002-2031-1055 2017 , 'Renal pharmacists' perceptions and current practices of assessing medication adherence in dialysis patients' , International journal of clinical pharmacy, vol. 40 , pp. 26-35 , doi: 10.1007/s11096-017-0574-8.

Full text not available from this repository.

Abstract

Background: Medication nonadherence is a major problem in chronic kidney failure patients undergoing dialysis. Pharmacistsplay a vital role in improving medication-related patient outcomes, reducing drug-related problems, and improving medicationadherence. However, little is known about how pharmacists assess medication adherence in dialysis patients. Objective:To measure pharmacists’ perceptions, current practices, and barriers to assessing adherence in dialysis patients. SettingAustralian renal-specialised pharmacists. Method: An online survey was conducted between March and May 2016. Surveyincluded five psychometric scales measuring perceived prevalence, contributors, effective methods, barriers, and confidenceto assess adherence on a 10-point Likert scale (1 = strongly disagree; 10 = strongly agree). Current practices were identifiedusing a 4-point graded response (1 = do not practice; 4 = practice for all). Main outcome measure: Perception scores,scale reliability, and responses to current practices questionnaire. Results: 41 pharmacists completed the survey (responserate, 91.1%). The majority (91.9%, n = 34; median = 8.0) agreed patients were nonadherent to medication. Time constraints(43.8%, n = 14) and hospital support (31.3%, n = 10) were perceived as barriers to assessment. Objective: blood monitoringwas frequently used to determine nonadherence (57.1%, n = 16), whereas subjective interviews were rarely conducted (27.6%,n = 8). Though all pharmacists support the presence of dedicated pharmacist for assessing adherence (100.0%, n = 33),only 24.2% were actually performing this function. Conclusion: Pharmacists were rarely assigned for adherence assessmentin dialysis settings. Established self-report methods were under-utilised compared to objective methods. Future researchshould investigate the effectiveness of pharmacists’ involvement in facilitating adherence promotion and early identificationof medication-related issues in dialysis patients.

Item Type: Article
Authors/Creators:Ghimire, S and Banks, C and Jose, MD and Castelino, RL and Zaidi, STR
Keywords: Australia, dialysis, kidney failure, chronic, medication adherence , renal pharmacists
Journal or Publication Title: International journal of clinical pharmacy
Publisher: Springer
ISSN: 2210-7703
DOI / ID Number: 10.1007/s11096-017-0574-8
Copyright Information:

Copyright 2017 Springer International Publishing AG, part of Springer Nature

Related URLs:
Item Statistics: View statistics for this item

Actions (login required)

Item Control Page Item Control Page
TOP